Not every plaintiff privacy firm operates the same way. While much of the privacy litigation bar pursues any consumer-facing website running standard advertising infrastructure, Pollock Cohen LLP has built its practice around a more deliberate thesis: that the most legally powerful — and most harmful — privacy violations happen not when pixels track generic browsing, but when they operate in contexts where users are engaging with their most sensitive personal information.
This New York-based boutique concentrates on cases where the data captured by tracking technology reveals something a person would never voluntarily share with an advertiser. A page visit that discloses a medical diagnosis. A loan application that exposes financial distress. A mental health platform visit that identifies a user’s treatment history. For Pollock Cohen, that is the target profile — and it is a narrow, precise one.
About the Firm
Pollock Cohen LLP is a plaintiff-side privacy litigation boutique based in New York, focused on consumer data protection class actions at the intersection of sensitive personal data and digital tracking technology. The firm’s practice is built on a specific and well-developed theory of harm: that advertising pixels and analytics tools become categorically more dangerous — legally, reputationally, and financially — when they are deployed in contexts where users are engaging with health information, financial data, or other deeply personal content.
Where other firms treating pixel litigation as a volume practice pursue defendants across the full consumer internet, Pollock Cohen’s case selection reflects deliberate prioritization. Healthcare systems, pharmacies, health insurance platforms, mental health services, financial services companies, and lenders are the defendant profile. The common thread is not industry classification — it is the sensitivity of what the user is doing on the page when the pixel fires.
The Legal Theories
Healthcare Data Tracking — CIPA, HIPAA Negligence Per Se, Common Law Privacy
Pollock Cohen’s healthcare cases target one of the most consequential compliance failures in digital marketing: the deployment of advertising pixels — Meta Pixel, Google Analytics, and others — on pages where users interact with protected health information. Hospital appointment scheduling pages, patient portals, prescription management platforms, and health insurance plan research tools have all been targets.
The firm’s legal framework in these cases typically layers several theories. State wiretapping claims under CIPA apply where defendants are California entities or where California users are affected. Common law invasion of privacy claims address the unconsented interception and disclosure of sensitive health data. And where HIPAA applies, the firm advances negligence per se theories: that HIPAA’s requirements establish the applicable standard of care for protecting patient data, and that deploying advertising pixels on HIPAA-covered pages — without a Business Associate Agreement covering the pixel vendor — constitutes a breach of that standard actionable in civil litigation.
The HIPAA negligence per se theory is particularly significant because it anchors the privacy violation to an established regulatory framework, making the standard of care less contested and the breach more straightforward to demonstrate.
Financial Data Tracking — Unauthorized Interception of Financially Sensitive Behavior
Pollock Cohen has extended the same framework to financial services: banking platforms, lending and loan application pages, insurance portals, and investment account interfaces where users enter or review sensitive financial information while advertising pixels simultaneously capture and transmit that behavioral data to Meta, Google, or other advertising networks.
The legal argument follows the same structure as the healthcare cases. When a user fills out a loan application and a pixel transmits that page visit — along with behavioral signals that can reveal financial distress, creditworthiness, or specific financial circumstances — to an advertising platform, the firm argues that the unauthorized interception of that behavior constitutes a privacy violation under multiple overlapping theories. The data transmitted is not generic browsing metadata. It is financially sensitive behavior with real-world consequences if disclosed.
Why Sensitive Data Cases Are Structurally Stronger
The conventional pixel case — generic browsing behavior, standard analytics, abstract harm — is legally viable but faces meaningful headwinds. Courts have narrowed pen register theories. Concrete harm can be difficult to establish. Class cohesion requires careful work.
Pollock Cohen’s focus on healthcare and financial data changes the structural dynamics of litigation in several ways:
Harm is concrete and emotionally legible. When a pixel transmits to Meta the fact that a user visited a page titled /hiv-testing-locations or /bankruptcy-filing-options, the harm is not abstract. Courts and juries understand it immediately. The gap between what the user thought was private and what was actually transmitted is vivid.
Sensitivity is legally recognized. Courts have consistently treated health and financial information as the most protected categories of personal data. The legal framework for heightened protection already exists — Pollock Cohen’s cases plug into it.
Regulatory overlap compounds defendant exposure. Healthcare data tracking does not create only civil litigation risk. It creates simultaneous HIPAA regulatory exposure, state medical privacy law exposure, and civil class action exposure. For defendants, that layered risk profile substantially increases the pressure to resolve.
Class cohesion is stronger. A class of patients whose protected health information was transmitted through advertising pixels on a hospital’s appointment scheduling page is more cohesive, more sympathetic, and easier to certify than a class defined by generic web browsing. The shared experience is specific and the harm is uniform.
Industries in Scope
Pollock Cohen’s case history and practice focus point to a specific set of defendant industries:
Hospitals and health systems where advertising pixels have been deployed on patient-facing pages — appointment scheduling, patient portals, symptom checkers, or any page accessible after authentication or that handles health-related queries.
Pharmacy chains and prescription management platforms where pixels on drug information pages, refill interfaces, or medication search tools capture health-revealing behavioral data.
Health insurance platforms where users research plan options, enter medical history information, or review coverage for specific conditions — all of which can reveal sensitive health circumstances to advertising networks.
Mental health and addiction treatment platforms, where the sensitivity of user engagement is acute and the consequences of disclosure particularly harmful.
Financial services companies — banks, lenders, insurance carriers, investment platforms — where users enter loan applications, review account information, or engage with financial planning tools while advertising pixels operate in the background.
How To Avoid Pollock Cohen Privacy Lawsuits?
If your business operates in any of these sectors and runs advertising technology on pages where users engage with sensitive data, the risk is not theoretical. Pollock Cohen’s practice is built around exactly this fact pattern, and the cases they pursue are constructed precisely because the intersection of sensitive data and advertising pixels creates strong, concrete, multi-theory claims. Running privacy compliance software from Captain Compliance can help you to avoid very expensive litigation.
Generic pixel audits are not enough. Standard cookie compliance reviews often focus on consent banners and opt-out mechanisms. Pollock Cohen’s cases are predicated on the presence of advertising pixels on sensitive pages regardless of what the consent banner says — because in healthcare and financial contexts, no consent mechanism makes pixel transmission of that data legally safe.
HIPAA compliance and pixel compliance are not separate workstreams. For healthcare defendants, the presence of Meta Pixel on a HIPAA-covered page is simultaneously a regulatory violation and a civil litigation predicate. Organizations that treat these as separate problems — one for the compliance team, one for marketing — are structurally exposed.
Mental health and addiction treatment context carries the sharpest edge. The sensitivity of what users are disclosing on these platforms, the specific harm of that information reaching advertising networks, and the emotional resonance of that harm in front of a court or jury make these cases among the most dangerous in Pollock Cohen’s portfolio.
The page-level question is the right question. The relevant inquiry is not whether your website has a consent banner. It is whether advertising technology fires on the specific pages where sensitive data is engaged. Page-level pixel audits, not site-level reviews, are the appropriate risk assessment tool.
Compliance Priorities
Treat sensitive pages as categorically off-limits for advertising pixels. Any page where users engage with health or financial information should be a pixel-free zone by policy, enforced technically, not managed through consent banners.
Implement server-side tag management for enforcement. Server-side tag management allows pixel exclusions to be enforced programmatically, so that content updates or CMS changes cannot accidentally reintroduce advertising technology on sensitive pages. Manual page-by-page management is not a durable control.
Align with HHS/OCR tracking technology guidance. For healthcare covered entities and business associates, the HHS Office for Civil Rights has issued specific guidance on the use of tracking technologies. Pixel configurations should be reviewed against that guidance and updated to reflect a clear separation between marketing pages and HIPAA-covered patient-facing pages.
Conduct page-level pixel audits across financial services surfaces. Every page where users enter or review financial data — loan applications, account dashboards, insurance claim interfaces — should be audited for pixel presence and cleared of advertising technology.
Implement and log explicit consent on any sensitive page where tracking is retained. Where any non-essential tracking is maintained on sensitive content pages, explicit opt-in consent — not opt-out, not implied consent — should gate it, and consent choices should be logged for audit purposes.
Sensitive Data Lawsuits
Pollock Cohen LLP’s practice represents one of the most targeted and legally coherent approaches in the plaintiff privacy bar. By concentrating on the cases where harm is most concrete, data most sensitive, and legal theories most powerful, the firm has constructed a litigation model that is structurally advantaged relative to generic pixel litigation.
For businesses operating at the intersection of sensitive personal data and digital advertising infrastructure, the compliance response is not a future project. The advertising pixel on a health information page, the analytics tag on a loan application form, the session replay tool on a patient portal — these are not marginal risks. They are the specific, identified fact patterns around which firms like Pollock Cohen build cases.
